Qingqian Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qingqian Zhao has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Lianyong Wang
The Third Central Clinical College Tianjin Medical University Tianjin China
2 shared publicationsWenqi Dong
The Third Central Clinical College Tianjin Medical University Tianjin China
2 shared publicationsYanhong Zhao
Department of Orthodontics School and Hospital of Stomatology Tianjin Medical University Tianjin China
2 shared publicationsYe Tian
Department of Orthopedics Central Hospital Tianjin University Tianjin China
2 shared publications- Yiming Zhang
The Third Central Clinical College Tianjin Medical University Tianjin China
2 shared publications Boyuan Du
Department of Orthopedics Central Hospital Tianjin University Tianjin China
1 shared publication
Latest Publications
Multifunctional Cerium Single‐Atom Photothermal Hydrogel for Regenerative Microenvironment Remodeling and Diabetic Bone Defect Repair
Diabetic bone defects feature persistent oxidative stress, chronic inflammation, impaired angiogenesis, and stem cell dysfunction, creating a regenerative microenvironment poorly addressed by single‐function biomaterials. We develop a pathology‐oriented multifunctional hydrogel integrating cerium single‐atom/polydopamine nanozymes and SDF‐1 within a GelMA matrix with near‐infrared (NIR)‐responsive photothermal functionality. The Ce SAs/PDA nanozyme scavenges multiple reactive oxygen species (ROS), while polydopamine provides photothermal activity and supports controlled release; SDF‐1 promotes bone marrow mesenchymal stem cell (BMSC) recruitment and angiogenesis. Under diabetic stress, the hydrogel reduces ROS accumulation, preserves mitochondrial membrane potential, alleviates DNA damage, and attenuates mesenchymal stem cell senescence, thereby restoring proliferative and osteogenic capacity. It also shifts macrophages toward a reparative phenotype, enhances endothelial migration and vascular network formation, and provides NIR‐triggered antibacterial activity. Transcriptomic and redox‐manipulation analyses further associate these effects with restoration of redox homeostasis and modulation of AGE‐RAGE‐ and PI3K‐AKT‐related signaling. In a diabetic calvarial defect model, the hydrogel enhances bone regeneration and neovascularization while reducing inflammatory and senescence‐associated signals. This study establishes a pathology‐oriented biomaterial strategy coupling single‐atom catalysis, photothermal regulation, and chemokine‐mediated repair to simultaneously address major pathological barriers to diabetic bone regeneration.
Multifunctional Cerium Single‐Atom Photothermal Hydrogel for Regenerative Microenvironment Remodeling and Diabetic Bone Defect Repair
Diabetic bone defects feature persistent oxidative stress, chronic inflammation, impaired angiogenesis, and stem cell dysfunction, creating a regenerative microenvironment poorly addressed by single‐function biomaterials. We develop a pathology‐oriented multifunctional hydrogel integrating cerium single‐atom/polydopamine nanozymes and SDF‐1 within a GelMA matrix with near‐infrared (NIR)‐responsive photothermal functionality. The Ce SAs/PDA nanozyme scavenges multiple reactive oxygen species (ROS), while polydopamine provides photothermal activity and supports controlled release; SDF‐1 promotes bone marrow mesenchymal stem cell (BMSC) recruitment and angiogenesis. Under diabetic stress, the hydrogel reduces ROS accumulation, preserves mitochondrial membrane potential, alleviates DNA damage, and attenuates mesenchymal stem cell senescence, thereby restoring proliferative and osteogenic capacity. It also shifts macrophages toward a reparative phenotype, enhances endothelial migration and vascular network formation, and provides NIR‐triggered antibacterial activity. Transcriptomic and redox‐manipulation analyses further associate these effects with restoration of redox homeostasis and modulation of AGE‐RAGE‐ and PI3K‐AKT‐related signaling. In a diabetic calvarial defect model, the hydrogel enhances bone regeneration and neovascularization while reducing inflammatory and senescence‐associated signals. This study establishes a pathology‐oriented biomaterial strategy coupling single‐atom catalysis, photothermal regulation, and chemokine‐mediated repair to simultaneously address major pathological barriers to diabetic bone regeneration.
- 25 September 2026
- Published by Springer Nature in Oncogene
- Vol. 45 (44) , 4791-4807
KIFC1 engages RUNX2/TGF-β signaling to promote lung cancer bone metastasis via disrupting bone homeostasis
Bone metastasis affects 30–40% of lung cancer patients, markedly reducing survival and quality of life, yet the underlying molecular mechanisms remain incompletely understood. Comparative transcriptomic profiling of primary lung tumors and paired bone metastases revealed pronounced KIFC1 enrichment in metastatic lesions, which correlated with poor bone metastasis-free survival. Functionally, KIFC1 enhanced lung cancer cell migration and adhesion toward osteoblast-like cells and upregulated the bone-homing factors CXCR4 and OPN. KIFC1 promoted osteoclast recruitment and differentiation while suppressing osteogenic differentiation, thereby disrupting bone homeostasis. Mechanistically, KIFC1 associated with RUNX2 through its C-terminal motor domain and promoted RUNX2 nuclear accumulation in a motor activity-, microtubule-, and importin-dependent manner. Nuclear RUNX2 directly activated TGFB1 transcription, resulting in preferential activation of the TGF-β/SMAD3 signaling pathway. Genetic silencing of RUNX2 or pharmacological inhibition of SMAD3 largely abrogated KIFC1-mediated pro-metastatic and pro-osteolytic effects. In vivo, KIFC1 knockdown reduced intraosseous tumor burden and alleviated trabecular bone loss, whereas KIFC1 overexpression exacerbated osteolytic lesions, which were mitigated by disrupting RUNX2/TGF-β/SMAD3 signaling. Collectively, our findings identify KIFC1-mediated RUNX2 nuclear transport as a previously unrecognized upstream regulatory mechanism that activates the TGF-β/SMAD3 axis during lung cancer bone metastasis, which provides a conceptual framework for the development of targeted therapeutic strategies.
- 25 September 2026
- Published by Springer Nature in Oncogene
- Vol. 45 (44) , 4791-4807
KIFC1 engages RUNX2/TGF-β signaling to promote lung cancer bone metastasis via disrupting bone homeostasis
Bone metastasis affects 30–40% of lung cancer patients, markedly reducing survival and quality of life, yet the underlying molecular mechanisms remain incompletely understood. Comparative transcriptomic profiling of primary lung tumors and paired bone metastases revealed pronounced KIFC1 enrichment in metastatic lesions, which correlated with poor bone metastasis-free survival. Functionally, KIFC1 enhanced lung cancer cell migration and adhesion toward osteoblast-like cells and upregulated the bone-homing factors CXCR4 and OPN. KIFC1 promoted osteoclast recruitment and differentiation while suppressing osteogenic differentiation, thereby disrupting bone homeostasis. Mechanistically, KIFC1 associated with RUNX2 through its C-terminal motor domain and promoted RUNX2 nuclear accumulation in a motor activity-, microtubule-, and importin-dependent manner. Nuclear RUNX2 directly activated TGFB1 transcription, resulting in preferential activation of the TGF-β/SMAD3 signaling pathway. Genetic silencing of RUNX2 or pharmacological inhibition of SMAD3 largely abrogated KIFC1-mediated pro-metastatic and pro-osteolytic effects. In vivo, KIFC1 knockdown reduced intraosseous tumor burden and alleviated trabecular bone loss, whereas KIFC1 overexpression exacerbated osteolytic lesions, which were mitigated by disrupting RUNX2/TGF-β/SMAD3 signaling. Collectively, our findings identify KIFC1-mediated RUNX2 nuclear transport as a previously unrecognized upstream regulatory mechanism that activates the TGF-β/SMAD3 axis during lung cancer bone metastasis, which provides a conceptual framework for the development of targeted therapeutic strategies.
- Open Access
- 14 May 2026
- Published by Elsevier in SSRN Electronic Journal
Rationally Engineered Bone-Targeting Calcium-Enriched Injectable Hydrogel for Microenvironmental Reprogramming at the Osteoporotic Bone–Implant Interface
Osteoporotic implant fixation failure arises from a resorption-biased peri-implant niche in which inflammation, oxidative stress, impaired angiogenesis, and defective osteogenesis collectively undermine stable osseointegration. Here, we report an injectable, bone-affinitive, calcium-enriched CAFG hydrogel as an interfacial biomaterial platform for reprogramming the osteoporotic peri-implant microenvironment and reinforcing implant anchorage. Constructed from oxidized fucoidan, gelatin, and CaCO3@ALN nanoparticles, the hydrogel integrates rapid in situ gelation, injectability, self-healing, wet adhesion, and local bone-targeting capability, enabling persistent interfacial retention and multifunctional bioactivity. Beyond structural stabilization, CAFG hydrogel actively remodels the pathological peri-implant niche by alleviating oxidative stress and inflammatory injury, promoting macrophage polarization toward a pro-regenerative phenotype, restoring endothelial angiogenic behavior, suppressing osteoclastogenesis, and enhancing osteogenic differentiation and matrix mineralization. Transcriptomic analysis further reveals that CAFG hydrogel-5% reverses LPS-induced inflammatory and osteoclast-associated programs while restoring extracellular matrix organization and osteogenesis-related signatures. In an ovariectomy-induced osteoporotic rat femoral screw model, local peri-implant delivery of CAFG hydrogel-5% significantly enhances peri-implant bone formation, collagen deposition, and vascularization, reduces inflammatory and osteolytic responses, and markedly improves pull-out strength. Collectively, this study establishes a multifunctional hydrogel-based strategy that couples interfacial stabilization with microenvironmental reprogramming, offering a promising materials framework for improving osseointegration and durable fixation in mechanically compromised bone.
- 14 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessRationally Engineered Bone-Targeting Calcium-Enriched Injectable Hydrogel for Microenvironmental Reprogramming at the Osteoporotic Bone–Implant Interface
Osteoporotic implant fixation failure arises from a resorption-biased peri-implant niche in which inflammation, oxidative stress, impaired angiogenesis, and defective osteogenesis collectively undermine stable osseointegration. Here, we report an injectable, bone-affinitive, calcium-enriched CAFG hydrogel as an interfacial biomaterial platform for reprogramming the osteoporotic peri-implant microenvironment and reinforcing implant anchorage. Constructed from oxidized fucoidan, gelatin, and CaCO3@ALN nanoparticles, the hydrogel integrates rapid in situ gelation, injectability, self-healing, wet adhesion, and local bone-targeting capability, enabling persistent interfacial retention and multifunctional bioactivity. Beyond structural stabilization, CAFG hydrogel actively remodels the pathological peri-implant niche by alleviating oxidative stress and inflammatory injury, promoting macrophage polarization toward a pro-regenerative phenotype, restoring endothelial angiogenic behavior, suppressing osteoclastogenesis, and enhancing osteogenic differentiation and matrix mineralization. Transcriptomic analysis further reveals that CAFG hydrogel-5% reverses LPS-induced inflammatory and osteoclast-associated programs while restoring extracellular matrix organization and osteogenesis-related signatures. In an ovariectomy-induced osteoporotic rat femoral screw model, local peri-implant delivery of CAFG hydrogel-5% significantly enhances peri-implant bone formation, collagen deposition, and vascularization, reduces inflammatory and osteolytic responses, and markedly improves pull-out strength. Collectively, this study establishes a multifunctional hydrogel-based strategy that couples interfacial stabilization with microenvironmental reprogramming, offering a promising materials framework for improving osseointegration and durable fixation in mechanically compromised bone.